Mus musculus papillomavirus 1 E8^E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation in vivo

ABSTRACT High-risk human papillomaviruses (PV) account for approximately 600,000 new cancers per year. The early protein E8^E2 is a conserved repressor of PV replication, whereas E4 is a late protein that arrests cells in G2 and collapses keratin filaments to facilitate virion release. While inactivation of the Mus musculus PV1 (MmuPV1) E8 start codon (E8-) increases viral gene expression, surprisingly, it prevents wart formation in FoxN1nu/nu mice. To understand this surprising phenotype, the impact of additional E8^E2 mutations was characterized in tissue culture and mice. MmuPV1 and HPV E8^E2 similarly interact with cellular NCoR/SMRT-HDAC3 co-repressor complexes. Disruption of the splice donor sequence used to generate the E8^E2 transcript or E8^E2 mutants (mt) with impaired binding to NCoR/SMRT-HDAC3 activates MmuPV1 transcription in murine keratinocytes. These MmuPV1 E8^E2 mt genomes also fail to induce warts in mice. The phenotype of E8^E2 mt genomes in undifferentiated cells resembles productive PV replication in differentiated keratinocytes. Consistent with this, E8^E2 mt genomes induced aberrant E4 expression in undifferentiated keratinocytes. In line with observations for HPV, MmuPV1 E4-positive cells displayed a shift to the G2 phase of the cell cycle. In summary, we propose that in order to enable both expansion of infected cells and wart formation in vivo, MmuPV1 E8^E2 inhibits E4 protein expression in the basal keratinocytes that would otherwise undergo E4-mediated cell cycle arrest. IMPORTANCE Human papillomaviruses (PVs) initiate productive replication, which is characterized by genome amplification and expression of E4 protein strictly within suprabasal, differentiated keratinocytes. Mus musculus PV1 mutants that disrupt splicing of the E8^E2 transcript or abolish the interaction of E8^E2 with cellular NCoR/SMRT-HDAC3 co-repressor complexes display increased gene expression in tissue culture but are unable to form warts in vivo. This confirms that the repressor activity of E8^E2 is required for tumor formation and genetically defines a conserved E8 interaction domain. E8^E2 prevents expression of E4 protein in basal-like, undifferentiated keratinocytes and thereby their arrest in G2 phase. Since binding of E8^E2 to NCoR/SMRT-HDAC3 co-repressor is required to enable expansion of infected cells in the basal layer and wart formation in vivo, this interaction represents a novel, conserved, and potentially druggable target. Human papillomaviruses (PVs) initiate productive replication, which is characterized by genome amplification and expression of E4 protein strictly within suprabasal, differentiated keratinocytes. Mus musculus PV1 mutants that disrupt splicing of the E8^E2 transcript or abolish the interaction of E8^E2 with cellular NCoR/SMRT-HDAC3 co-repressor complexes display increased gene expression in tissue culture but are unable to form warts in vivo. This confirms that the repressor activity of E8^E2 is required for tumor formation and genetically defines a conserved E8 interaction domain. E8^E2 prevents expression of E4 protein in basal-like, undifferentiated keratinocytes and thereby their arrest in G2 phase. Since binding of E8^E2 to NCoR/SMRT-HDAC3 co-repressor is required to enable expansion of infected cells in the basal layer and wart formation in vivo, this interaction represents a novel, conserved, and potentially druggable target.

[1]  T. Iftner,et al.  Transcription Properties of Beta-HPV8 and HPV38 Genomes in Human Keratinocytes , 2022, Journal of virology.

[2]  F. Stubenrauch,et al.  Functions of Papillomavirus E8^E2 Proteins in Tissue Culture and In Vivo , 2022, Viruses.

[3]  T. Iftner,et al.  Restriction of viral gene expression and replication prevents immortalization of human keratinocytes by a beta-human papillomavirus , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Ke-Jia Zheng,et al.  Role of E6 in Maintaining the Basal Cell Reservoir during Productive Papillomavirus Infection , 2022, Journal of virology.

[5]  E. Fuchs,et al.  Building and Maintaining the Skin. , 2021, Cold Spring Harbor perspectives in biology.

[6]  J. Casanova,et al.  Human genetic and immunological dissection of papillomavirus-driven diseases: new insights into their pathogenesis. , 2021, Current opinion in virology.

[7]  S. Brendle,et al.  Mouse Papillomavirus L1 and L2 Are Dispensable for Viral Infection and Persistence at Both Cutaneous and Mucosal Tissues , 2021, Viruses.

[8]  T. Iftner,et al.  Expression of E8^E2 Is Required for Wart Formation by Mouse Papillomavirus 1 In Vivo , 2021, Journal of Virology.

[9]  T. Iftner,et al.  Contribution of HDAC3 to transcriptional repression by the human papillomavirus 31 E8^E2 protein. , 2020, The Journal of general virology.

[10]  S. Schwartz,et al.  Efficient production of HPV16 E2 protein from HPV16 late mRNAs spliced from SD880 to SA2709. , 2020, Virus research.

[11]  P. Lambert,et al.  Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis , 2020, Journal of Virology.

[12]  E. Treuter,et al.  The Nuclear Receptor—Co-repressor Complex in Control of Liver Metabolism and Disease , 2019, Front. Endocrinol..

[13]  M. Lazar,et al.  Integrative regulation of physiology by histone deacetylase 3 , 2018, Nature Reviews Molecular Cell Biology.

[14]  P. Stern,et al.  Opportunities and challenges for human papillomavirus vaccination in cancer , 2018, Nature Reviews Cancer.

[15]  D. Gotte,et al.  The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues , 2017, PLoS pathogens.

[16]  M. Plummer,et al.  Worldwide burden of cancer attributable to HPV by site, country and HPV type , 2017, International journal of cancer.

[17]  Qiang Sun,et al.  The Papillomavirus Episteme: a major update to the papillomavirus sequence database , 2016, Nucleic Acids Res..

[18]  I. Frazer,et al.  Role of Ultraviolet Radiation in Papillomavirus-Induced Disease , 2016, PLoS pathogens.

[19]  B. Maček,et al.  Interaction of NCOR/SMRT Repressor Complexes with Papillomavirus E8^E2C Proteins Inhibits Viral Replication , 2016, PLoS pathogens.

[20]  T. Iftner,et al.  Characterization of the Human Papillomavirus 16 E8 Promoter , 2015, Journal of Virology.

[21]  D. Lowy,et al.  Strain-Specific Properties and T Cells Regulate the Susceptibility to Papilloma Induction by Mus musculus Papillomavirus 1 , 2014, PLoS pathogens.

[22]  T. Iftner,et al.  The Viral E8^E2C Repressor Limits Productive Replication of Human Papillomavirus 16 , 2013, Journal of Virology.

[23]  M. Ustav,et al.  Mapping of Betapapillomavirus Human Papillomavirus 5 Transcription and Characterization of Viral-Genome Replication Function , 2013, Journal of Virology.

[24]  Alison A McBride,et al.  The papillomavirus E2 proteins. , 2013, Virology.

[25]  J. Archambault,et al.  The E1 proteins. , 2013, Virology.

[26]  J. Doorbar The E4 protein; structure, function and patterns of expression. , 2013, Virology.

[27]  L. Laimins,et al.  Differentiation-Dependent Changes in Levels of C/EBPβ Repressors and Activators Regulate Human Papillomavirus Type 31 Late Gene Expression , 2012, Journal of Virology.

[28]  J. Schwabe,et al.  Nuclear hormone receptor co-repressors: Structure and function , 2012, Molecular and Cellular Endocrinology.

[29]  L. Chow,et al.  Human Papillomavirus (HPV) E7 Induces Prolonged G2 following S Phase Reentry in Differentiated Human Keratinocytes* , 2011, The Journal of Biological Chemistry.

[30]  M. Ustav,et al.  Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. , 2010, Virology.

[31]  Cary A Moody,et al.  Human papillomavirus oncoproteins: pathways to transformation , 2010, Nature Reviews Cancer.

[32]  Jennifer A. Smith,et al.  NCoR1 Mediates Papillomavirus E8^E2C Transcriptional Repression , 2010, Journal of Virology.

[33]  L. Chow,et al.  Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. , 2009, Genes & development.

[34]  L. Turek,et al.  The E8∧E2 Gene Product of Human Papillomavirus Type 16 Represses Early Transcription and Replication but Is Dispensable for Viral Plasmid Persistence in Keratinocytes , 2008, Journal of Virology.

[35]  L. Laimins,et al.  Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding. , 2008, Virology.

[36]  T. Iftner,et al.  Inhibition of Transcription and DNA Replication by the Papillomavirus E8⁁E2C Protein Is Mediated by Interaction with Corepressor Molecules , 2008, Journal of Virology.

[37]  Joachim Goedhart,et al.  UvA-DARE ( Digital Academic Repository ) Optimization of fluorescent proteins for novel quantitative multiparameter microscopy approaches , 2007 .

[38]  L. Laimins,et al.  Induction of the Human Papillomavirus Type 31 Late Promoter Requires Differentiation but Not DNA Amplification , 2005, Journal of Virology.

[39]  C. Meyers,et al.  Genetic Analysis of the Human Papillomavirus Type 31 Differentiation-Dependent Late Promoter , 2005, Journal of Virology.

[40]  J. Grainger,et al.  Cooperation between Different Forms of the Human Papillomavirus Type 1 E4 Protein To Block Cell Cycle Progression and Cellular DNA Synthesis , 2004, Journal of Virology.

[41]  T. Iftner,et al.  The Papillomavirus E8∧E2C Protein Represses DNA Replication from Extrachromosomal Origins , 2003, Molecular and Cellular Biology.

[42]  A. Ishimoto,et al.  Modulation of the Cell Division Cycle by Human Papillomavirus Type 18 E4 , 2002, Journal of Virology.

[43]  T. Iftner,et al.  The E8 Domain Confers a Novel Long-Distance Transcriptional Repression Activity on the E8^E2C Protein of High-Risk Human Papillomavirus Type 31 , 2001, Journal of Virology.

[44]  T. Iftner,et al.  The E8^E2C Protein, a Negative Regulator of Viral Transcription and Replication, Is Required for Extrachromosomal Maintenance of Human Papillomavirus Type 31 in Keratinocytes , 2000, Journal of Virology.

[45]  D. Klumpp,et al.  Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1. , 1999, Virology.

[46]  T. Iftner,et al.  Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA , 1996, Journal of virology.

[47]  L. Laimins,et al.  Differentiation-dependent expression of E1--E4 proteins in cell lines maintaining episomes of human papillomavirus type 31b. , 1995, Virology.

[48]  M. Stanley,et al.  Immunoelectron microscopical localization of human papillomavirus type 16 L1 and E4 proteins in cervical keratinocytes cultured in vivo. , 1993, The Journal of investigative dermatology.

[49]  M. Hummel,et al.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes , 1992, Journal of Virology.

[50]  J. Millar,et al.  Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. , 2002, Journal of virology.

[51]  W. Greene,et al.  Duration of nuclear NF-kappaB action regulated by reversible acetylation. , 2001, Science.